Prepared statement for the Senate Committee on Foreign Relations

An effective strategy to engage China's health-care sector requires the U.S. government to continue promoting business opportunities for U.S. biopharmaceutical firms, hospital groups, and insurance c…

In his testimony before the Senate Foreign Relations Subcommittee on Africa and Global Health Policy, Thomas J. Bollyky argues that continued U.S. and private sector leadership on the unfinished heal…

   In testimony before the United States-China Economic and Security Commission on April 27, 2016, Yanzhong Huang discussed China’s 13th Five Year Plan in the context of China’s healthcare system …

In his testimony before the Congressional-Executive Commission on China, Yanzhong Huang discusses China's recent public health crises. He focused on two areas: encouraging further government transpar…